Questions about Multiple Sclerosis
How does oral cladribine change immune cells in relapsing multiple sclerosis?
Oral cladribine depletes certain B and T cells in the blood and CSF, reduces microglial activation, and allows recovery of naive B cells, which may help control relapsing MS.
Full answer →What active therapeutic interventions are available for Multiple Sclerosis patients in inpatient rehabilitation?
Inpatient rehabilitation for MS includes gait training, robot-assisted therapy, strength, balance, and aerobic exercises, all showing mobility and fatigue benefits.
Full answer →Are CAR-T cell therapies currently being used to treat Multiple Sclerosis according to recent reviews?
CAR-T cell therapies are not yet approved for MS but are being tested in clinical trials, with early results showing safety and potential benefit.
Full answer →Can aerobic or strength training help reduce fatigue in people with Multiple Sclerosis?
Yes, both aerobic and strength training can reduce fatigue in people with multiple sclerosis, with studies showing similar benefits from each modality.
Full answer →How much has the incidence of Multiple Sclerosis in women of childbearing age increased since 1990?
The incidence of Multiple Sclerosis in women of childbearing age has increased by 48% from 1990 to 2021, according to a global burden of disease study.
Full answer →What is the success rate for pain relief in Multiple Sclerosis patients treated with microvascular decompression?
Microvascular decompression for trigeminal neuralgia in multiple sclerosis patients has a long-term pain-free success rate of about 30.2%, based on a 2024 systematic review.
Full answer →